期刊文献+

顺胃丸合驱风脐帖治疗功能性消化不良50例临床观察 被引量:1

Effect of Oral Use of Shunwei Pin and External Application of Qufeng Bellybut-ton Raster on Functional Dyspepsia: An Observation of 50 Cases
暂未订购
导出
摘要 目的:观察顺胃丸合驱风脐帖治疗功能性消化不良的临床疗效。方法:将100例患者随机分为2组各50例,治疗组采用自拟顺胃丸(由栀子、柴胡、茯苓、白芍、白术、木香、青皮、陈皮、枳实、厚朴、延胡索、乌药、瓜萎、法半夏、神曲、莱菔子、黄芪、海螵蛸、煅海蛤壳组成)口服,配合驱风脐帖(由冰片、麝香、朱砂、苏合香油、丁香、木香、香附、乳香、细辛、荜茇、白术组成)贴脐治疗。对照组采用多潘立酮、法莫替丁口服治疗。结果:总有效率治疗组为90%,对照组为72%,2组比较,差异有显著性意义(P<0.05),治疗组优于对照组。治疗后2组症状总积分均显著减少,与治疗前比较,差异均有非常显著性意义(P< 0.01),说明2组治疗均有肯定疗效。但治疗组症状总积分减少较对照组更为显著,2组治疗后比较,差异有显著性意义(P<0.05),显示治疗组疗效优于对照组。结论:顺胃丸合驱风脐帖治疗功能性消化不良疗效显著。 Objective: To observe the effect of oral use of Shunwei Pill (SP) and external application of Qufeng Bellybutton Plaster (QBP) on functional dyspepsia (FD). Methods: One hundred FD patients were equally randomized into 2 groups. Croup A received oral use of self - prepared SP (mainly composed of Fructus Gardeni-ae, Radix Bupleuri, Poria, Radix Paeoniae Alba, Rhizoma Atractylodis Macrocepha-lae, Radix Aucklandiae, Pericarpium Citri Reticulatae Viride, Pericarpium Citri Retic-ulatae, Fructus Aurantii Immaturus, Cortex Magnoliae Officinalis, etc. ) and external application of QBP (mainly composed of Bomeolum Syntheticum, Moschua, Cinnabaris, Styrax, Flos Caryophylli, Radix Aucklandiae, Rhizoma Cyperi, Olibanum, Herba Asar-i, Fructus Piperis Longi, Rhizoma Atractylodis Macrocephalae, etc. ) on bellybutton. Croup B received oral usel of domperidone and famotidine. Results: The total effective rate was 90% in group A and 72% in group B (P < 0.05). The total symptoms scores decreased in the two groups after treatment (P < 0. 01 compared with those before treatment), and the effect was superior in group A than that in group B (P < 0. 05). Conclusion: Oral use of SP and external application of QBP have a certain effect for the treatment of FD.
机构地区 潮州市中医医院
出处 《新中医》 CAS 北大核心 2008年第3期38-39,共2页 New Chinese Medicine
基金 广东省中医药局建设中医药强省科研课题(编号:1060001)
  • 相关文献

参考文献3

二级参考文献20

  • 1[1]Drossman DA.[J]. Gut, 1999,45(Suppl Ⅱ ): Ⅱ 1-Ⅱ5.
  • 2[2]Clouse RE, Richter JE, Heading RC.[J]. Gut,1999,45(Suppl Ⅱ ): Ⅱ31-Ⅱ36.
  • 3[3]Moser G, Wenzel-Abatzi TA, Stelzeneder M.[J].Arch Intern Med, 1998,158:1365-1373.
  • 4[4]Rao SSC, Gregersen H, Hayek B.[J]. Ann Intern Med, 1996,124:950-958.
  • 5[5]Fass R, Fennerty MB, Ofman JJ.[J]. Gastroenterology, 1988,115:42-49.
  • 6[6]Watson RGP, Tham TCK, Johnston BT.[J]. Gut,1997,40: 587-590.
  • 7[7]Talley NJ, Stanghellini S, Heading RC.[J]. Gut,1999,45(Suppl Ⅱ ): Ⅱ37-Ⅱ42.
  • 8[8]Talley NJ, SilversteinM, Agreus L.[J]. Gastroenterology, 1998,114:582-595.
  • 9[9]Tack J, Piessevaux H, 'Coulie B.[J]. Gastroenterology, 1998,115:1586-1587.
  • 10[10]Talley NJ, Meineche-Schmidt V, Pare P.[J]. Aliment Pharmacol Ther, 1998,12:1055-1065.

共引文献575

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部